Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: a case report
IDCases
; 2023.
Article
in English
| EuropePMC | ID: covidwho-2273304
ABSTRACT
Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who was receiving dexamethasone and tocilizumab. The patient's symptoms improved with appropriate diagnosis and antimicrobial therapy, and he fortunately returned to society without any neurological sequelae of meningitis.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Type of study:
Case report
Language:
English
Journal:
IDCases
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS